<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04618848</url>
  </required_header>
  <id_info>
    <org_study_id>PR0156</org_study_id>
    <nct_id>NCT04618848</nct_id>
  </id_info>
  <brief_title>Performance Evaluation Study</brief_title>
  <official_title>Performance Evaluation Protocol for Sight Diagnostics' OLO CBC Analyzer by Ichilov Oncology Daily Care Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sight Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sight Diagnostics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to establish OLO's performance accuracy of CBC results for finger prick&#xD;
      samples across the OLO reportable range, and particularly around relevant medical decision&#xD;
      points&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to establish OLO's performance accuracy of CBC results for finger prick&#xD;
      samples across the OLO reportable range, and particularly around relevant medical decision&#xD;
      points.&#xD;
&#xD;
      The evaluation will include two studies:&#xD;
&#xD;
        1. A matrix study will compare a capillary sample collected via finger prick with a venous&#xD;
           sample collected into a blood tube, both scanned on OLO.&#xD;
&#xD;
        2. A method comparison study will compare Sight OLO to the site reference analyzer using a&#xD;
           venous sample collected into a blood tube.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CBC Comparison</measure>
    <time_frame>Immediately after sample collection is completed</time_frame>
    <description>Comparison between CBC results obtained from the Sight OLO and the reference device in venous and capillary samples covering medical decision points relevant to onclology patient</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hematology</condition>
  <arm_group>
    <arm_group_label>Adult Oncology Patients</arm_group_label>
    <description>Adult oncology patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fingerstick blood draw</intervention_name>
    <description>Each participant shall be pricked twice in order to perform CBC test</description>
    <arm_group_label>Adult Oncology Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Oncologic patient&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Blood samples will be collected from oncologic patients older than 18 years old&#xD;
             arriving at the oncologic daily care center of Ichilov hospital, with predefined&#xD;
             normal and abnormal blood counts&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient younger than 18 years old&#xD;
&#xD;
          -  Visibly hemolyzed specimens (sample plasma should be checked for hemolysis by&#xD;
             technician while selection of specimen from tube racks).&#xD;
&#xD;
          -  Visibly clotted specimens (Reasonable to assume that samples processed with clinical&#xD;
             reported results are not clotted).&#xD;
&#xD;
          -  A sample that is not successfully scanned on OLO within 3 attempts (e.g. rejected due&#xD;
             to irregular cell morphology, or microscopically visible hemolysis).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yochay Eshel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sponsor GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yochay Eshel</last_name>
    <phone>+972-52-8505747</phone>
    <email>yochay@sightdx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tahel Naveh</last_name>
    <phone>+972-54-6412600</phone>
    <email>tahel@sightdx.com</email>
  </overall_contact_backup>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hematology</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 27, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/48/NCT04618848/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

